SCHEMBL15939833

SCHEMBL15939833

CC(C)c1cccc(C(C)C)c1-n1c(-c2ccccc2)nc2ccc(-c3ccccc3)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
ALOX15 P16050 2/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 5/20 0.39
NPC1 O15118 4/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
KDM4E B2RXH2 5/20 0.39
GAA P10253 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
PDE10A Q9Y233 1/20 0.39
TP53 P04637 4/20 0.38
MAPT P10636 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15940200 0.91 ALDH1A1 (0.43) ALDH1A1ALOX15TSHRGAAESR1
SCHEMBL18371992 0.90 ESR1 (0.43) ALDH1A1ALOX15TSHRRAB9AKDM4E
SCHEMBL2456142 0.87 ESR1 (0.51) ALDH1A1ALOX15TSHRRAB9ANPC1
SCHEMBL20458041 0.86 ALDH1A1 (0.44) ALDH1A1ALOX15TSHRRAB9ANPC1
SCHEMBL15940161 0.86 RAB9A (0.40) ALDH1A1ALOX15RAB9ANPC1CASP3
SCHEMBL15316051 0.86 KDM4E (0.46) ALDH1A1ALOX15TSHRRAB9ANPC1
SCHEMBL13299533 0.83 NLRP3 (0.52) ALDH1A1ALOX15TSHRRAB9ANPC1
SCHEMBL13299522 0.82 ESR1 (0.49) ALDH1A1ALOX15TSHRRAB9ANPC1
SCHEMBL18371991 0.82 MAPK10 (0.48) ALDH1A1TSHRRAB9AKDM4EESR1
SCHEMBL15316056 0.82 ESR1 (0.41) ALDH1A1ALOX15TSHRRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832456-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-28 US disclosed
US-10400163-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-03 US disclosed
US-10400163-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-03 US disclosed
US-20140225069-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2014-08-14 US disclosed
US-20140225069-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2014-08-14 US disclosed
US-20140225069-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2014-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11832456-B2 Organic electroluminescent materials and devices CPNE4, CYBA, EPCAM ALDH1A1 332/4885ALOX15 573/4885TSHR 4046/4885
US-10400163-B2 Organic electroluminescent materials and devices INTS9, SRSF9, PRMT9 ALDH1A1 2082/4885ALOX15 4095/4885TSHR 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.